Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis
Eosinophilic esophagitis (EE) is a chronic immune/antigen-mediated esophageal inflammatory disease for which off-label topical corticosteroids (e.g., budesonide) are widely used in clinic. In general, thickening excipients are mixed with industrial products to improve the residence time of the drug...
Saved in:
Main Authors: | Antonella Casiraghi (Author), Chiara Grazia Gennari (Author), Umberto Maria Musazzi (Author), Marco Aldo Ortenzi (Author), Susanna Bordignon (Author), Paola Minghetti (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reply to "Comment on Casiraghi et al. 'Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis' 2020, <i>12</i>, 211"
by: Antonella Casiraghi, et al.
Published: (2020) -
Mucoadhesive Budesonide Solution for the Treatment of Pediatric Eosinophilic Esophagitis
by: Antonio Spennacchio, et al.
Published: (2024) -
Comment on Casiraghi et al. "Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis" 2020, <i>12</i>, 211
by: Eyal Zur
Published: (2020) -
Paediatric formulation: budesonide 0.1 mg/mL viscous oral solution for eosinophilic esophagitis using cyclodextrins
by: Ey Caroline, et al.
Published: (2018) -
Topical Administration of Cannabidiol: Influence of Vehicle-Related Aspects on Skin Permeation Process
by: Antonella Casiraghi, et al.
Published: (2020)